Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Teva Pharmaceutical Industries Ltd. AGM Information 2007

Jun 13, 2007

7082_rns_2007-06-13_aa99b187-bd11-41cc-9236-24b8df747db0.htm

AGM Information

Open in viewer

Opens in your device viewer

_________

C007��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.2530Corporation no: 520013954Stock Exchange/Market: ���310428P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267297 , 03-9267281 Fax: 03-9267429E.mail address: [email protected] of transmission: 13/06/2007              Time of broadcast: 10:12 09:55:14

Reference: 2007-02-425996

Israel Securities Authority Tel Aviv Stock Exchange
www.isa.gov.il www.tase.co.il
Complementary report for a report sent on date 06/06/2007 whose reference number was 2007-02-418238
Main details added/ completed:
Attached below are the voting card the company's proxy statement

Annual General Meeting / Special MeetingRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000Only for corporation incorporated in Israel

On 17/07/2007 at 17:00 the corporation will hold it's annual general meetingat Teva's executive offices at 5 Basel street, Petach Tikva, Israel

According to section 182 _________ of the Companies law, 5759-1999, only shareholders of record at the close of business 11/06/2007 will be entitled to notice of, and to vote at, the Meeting.

Attached hereto is the report �����������130607_isa.pdf

Attached hereto is the proxy statement proxyenglish2007_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 28/02/2007
- - -
Name of the Signatory: : Karniel Uzi , , Position of Signatory in the reporting corporation: General Counsel & Company Secretary
Basel Telephone: 03-9267297 , Facsimile: 03-9267429 , E-mail: [email protected]